INTERNATIONAL PATENT: HOOKIPA BIOTECH GMBH FILES APPLICATION FOR "MODIFIED ARENAVIRUS PARTICLES EXPRESSING CANCER TESTIS ANTIGENS AS CANCER IMMUNOTHERAPIES"

GENEVA, Sept. 21 -- HOOKIPA BIOTECH GMBH (Helmut-Qualtinger-Gasse 21030 Wien) filed a patent application (PCT/EP2025/057114) for "MODIFIED ARENAVIRUS PARTICLES EXPRESSING CANCER TESTIS ANTIGENS AS CANCER IMMUNOTHERAPIES" on Mar 14, 2025. With publication no. WO/2025/191169, the details related to the patent application was published on Sep 18, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): RAGUZ, Josipa (c/o Hookipa Biotech GmbHHelmut-Qualtinger-Gasse 21030 Vienna), AHMADI-ERBER, Sarah (c/o Hookipa Biotech GmbHHelmut-Qualtinger-Gasse 21030 Vienna), SCHMIDT, Sarah (c/o Hookipa Biotech GmbHHe...